TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,225,000 | +239.4% | 698,131 | +103.2% | 0.00% | +200.0% |
| Q1 2021 | $5,665,000 | +80.7% | 343,529 | +101.9% | 0.00% | – |
| Q4 2020 | $3,135,000 | +70.2% | 170,153 | +25.7% | 0.00% | – |
| Q3 2020 | $1,842,000 | +132.3% | 135,350 | +205.8% | 0.00% | – |
| Q2 2020 | $793,000 | +169.7% | 44,266 | +50.3% | 0.00% | – |
| Q1 2020 | $294,000 | -45.4% | 29,456 | -55.4% | 0.00% | – |
| Q4 2019 | $538,000 | +427.5% | 66,089 | +545.0% | 0.00% | – |
| Q3 2019 | $102,000 | +1940.0% | 10,247 | +2430.1% | 0.00% | – |
| Q2 2019 | $5,000 | -89.6% | 405 | -91.4% | 0.00% | – |
| Q1 2019 | $48,000 | -58.3% | 4,708 | -69.4% | 0.00% | – |
| Q4 2018 | $115,000 | -26.3% | 15,378 | -1.2% | 0.00% | – |
| Q3 2018 | $156,000 | – | 15,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |